Erythema in diseases classified elsewhere

L12_ERYTHINOTH

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L54* Cause of death: ICD-10 — L54* 2 out of 7 registries used, show all original rules.	77
4. Check minimum number of events None	77
5. Include endpoints None	77
6. Filter based on genotype QC (FinnGen only)	76

Control definitions (FinnGen only)

Control exclude: L12_URTICARIAERYTHEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2

NAME	L12_ERYTHINOTH
CONTROL_EXCLUDE	L12_URTICARIAERYTHEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L54
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L54
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Erythema in diseases classified elsewhere based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	461	302	158
Only index persons	439	286	153
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.00
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	56.68	58.12	53.91
Only index persons	56.26	57.79	53.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	76	51	25
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	54.74	52.09	60.16

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
77: Matched controls
770

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L548, A692,

ICD-10 Finland

+∞

52.1

A69.2

ICD-10 Finland

Lyme disease

19.3

32.9

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

+∞

19.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

8.5

15.8

L54.0*I00

ICD-10 Finland

Erythema marginatum in acute rheumatic fever

+∞

8.5

L30.9

ICD-10 Finland

Dermatitis, unspecified

4.0

7.3

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

6.67

11.04

2.3

1.2

64.43

—

au/ml

—

(40761535) Cells panel - Urine sediment

4.57

7.53

5.0

2.9

—

(3013707) Erythrocyte sedimentation rate by Westergren method

506

4.49

5.29

6.5

4.3

11.70

11.75

mm/h

0.01

461

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

654

+∞

4.88

18.5

13.4

18.00

20.99

mg/l

0.52

515

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

3.06

4.15

10.9

7.7

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

4.95

3.79

1.2

1.6

—

(40758558) Short blood count panel - Blood

172

2.34

3.13

9.7

6.7

—

(3001604) Monocytes [#/volume] in Blood

334

2.28

2.99

9.9

5.6

0.58

0.56

e9/l

0.34

297

(40768443) Skin Pathology biopsy report

4.49

2.99

1.6

1.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

144

2.35

2.96

6.9

3.2

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

4.29

2.88

2.7

1.4

1.10

1.21

g/l

—

(3020891) Body temperature

3.80

2.81

7.6

5.1

—

(36304419) Bacteria [Presence] in Urine

165

2.22

2.70

3.1

2.9

—

(40760892) CBC W Ordered Manual Differential panel - Blood

317

2.01

2.29

10.3

5.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2.28

2.10

3.6

2.0

31.57

28.90

0.54

(3000991) Gas panel - Venous blood

2.69

2.03

4.6

6.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

4.78

1.97

1.8

1.5

—

(3030467) Casts [#/volume] in Urine by Automated count

176

1.93

1.91

3.5

3.1

0.20

0.34

e6/l

0.44

132

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

120

2.03

1.86

1.2

1.3

14.09

55.84

iu/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

313

1.85

7.4

5.6

0.00

estimate

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

4.37

1.85

1.6

1.1

—

(3022217) INR in Platelet poor plasma by Coagulation assay

304

1.84

22.4

14.1

1.25

1.21

inr

—

(3035350) Ketones [Presence] in Urine by Test strip

314

1.84

1.82

5.9

3.9

0.00

estimate

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

533

2.19

1.81

10.2

7.1

75.70

77.36

u/l

0.19

496

(3000494) Fungus identified in Specimen by Culture

2.21

1.79

1.3

1.5

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

108

2.01

1.70

3.4

2.7

1.31

0.87

e6/l

0.42

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

3.33

1.69

1.0

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

124

1.95

1.69

1.3

1.2

42.63

12.39

u/ml

—

(3031040) Bacteria [#/volume] in Urine by Automated count

419

1.85

1.68

5.6

3.9

—

36.60

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

619

2.44

1.67

4.9

5.1

1.95

1.92

mu/l

0.08

565

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

245

1.79

1.67

6.3

4.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

2.46

1.63

3.3

2.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

3.16

1.61

1.0

1.3

—

3.70

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

3.16

1.61

1.0

1.3

—

1.88

—

(3002582) Erythrocytes [#/volume] in Urine

194

1.79

1.59

3.9

3.1

10.68

45.41

e6/l

1.14

151

(3018095) Leukocytes [#/volume] in Urine

230

1.76

1.58

4.0

3.4

16.10

54.59

e6/l

0.90

162

(3023368) Bacteria identified in Blood by Culture

169

1.81

1.56

3.2

4.3

—

(3009542) Hematocrit [Volume Fraction] of Blood

725

+∞

1.56

30.7

19.7

39.73

40.06

0.15

685

(3014051) Protein [Presence] in Urine by Test strip

3.49

1.55

3.6

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

189

1.76

1.48

2.7

2.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.18

1.47

1.7

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.18

1.47

1.9

1.4

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.27

1.46

1.6

1.3

—

(3026008) Bacteria identified in Urine by Culture

190

1.74

1.45

4.2

3.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.35

1.42

2.6

3.1

0.66

0.68

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

254

1.69

1.42

5.1

3.7

20.10

33.64

ng/l

0.78

173

(3029937) Albumin [Presence] in Urine by Test strip

165

1.76

1.42

6.8

3.7

0.00

estimate

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

293

1.67

1.38

2.9

2.3

—

(3019060) Gas panel - Arterial blood

2.23

1.35

7.9

4.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.23

1.35

2.6

3.1

1.26

1.17

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

214

1.66

1.27

3.6

3.3

2.35

2.36

mmol/l

0.22

190

(3045414) Leukocytes [Presence] in Urine

2.51

1.27

3.5

1.8

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

137

1.73

1.22

1.3

1.7

495.63

452.34

pmol/l

0.26

118

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

138

1.72

1.19

3.2

2.1

—

(3012544) pH of Venous blood

1.97

1.17

2.3

3.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

2.11

1.16

1.6

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.83

1.14

2.2

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.85

1.07

1.6

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

522

1.68

1.05

4.4

4.2

15.20

14.80

pmol/l

0.49

474

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1.76

1.03

3.9

4.3

27.90

33.32

—

(3019309) Folate [Moles/volume] in Red Blood Cells

111

1.68

0.98

2.1

1.7

2122.27

1176.46

nmol/l

1.50

(40768804) Tissue Pathology biopsy report

265

1.51

0.94

1.7

2.0

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1.72

0.92

1.2

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.84

0.92

2.2

1.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1.68

0.89

2.7

0.79

0.82

mmol/l

0.59

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.08

0.89

8.8

6.3

24.38

25.29

mmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

439

1.48

0.83

6.4

4.2

—

(40768793) Breast Pathology biopsy report

0.00

0.80

0.0

1.2

—

(3042936) Bacteria identified in Isolate by Culture

1.69

0.77

2.7

2.2

—

(1761868) Lipid panel - Serum or Plasma

263

0.68

0.73

2.1

3.0

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.59

0.68

8.5

6.2

103.38

103.52

mmol/l

0.03

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

185

1.43

0.67

4.1

3.0

845.42

865.22

ng/l

0.02

158

(4034850) Laboratory test

1.77

0.65

19.0

12.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

114

0.58

0.64

1.4

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

0.00

0.61

0.0

1.0

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.61

0.0

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

637

1.58

0.58

7.2

5.8

41.53

40.24

mmol/mol

0.42

595

(3019225) pH of Specimen

1.54

0.56

9.3

3.4

—

(3000330) Specific gravity of Urine by Test strip

1.63

0.56

5.7

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.59

0.56

1.7

1.5

—

(3021589) Normoblasts [#/volume] in Blood

306

1.33

0.55

10.0

9.6

0.00

e9/l

0.50

256

(3003694) ABO and Rh group [Type] in Blood

164

1.39

0.54

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.54

0.53

1.2

1.0

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1.43

0.45

2.6

1.4

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.65

0.44

1.4

—

(3025941) Bacteria identified in Stool by Culture

1.60

0.43

1.4

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

668

1.53

0.43

5.7

4.6

4.87

4.70

mmol/l

0.75

613

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1.46

0.40

7.2

3.3

5.08

5.24

kpa

—

(3012516) Albumin [Mass/volume] in Urine

201

1.28

0.39

3.7

3.1

17.06

51.55

mg/l

1.43

139

(3019832) Treponema pallidum Ab [Presence] in Serum

1.42

0.39

1.2

1.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.38

0.38

4.5

2.8

1.46

3.91

e6/l

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.46

0.36

1.2

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1.43

0.36

1.3

1.4

1.38

1.15

g/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.43

0.36

1.3

1.2

—

(40761536) Microorganisms panel - Urine sediment

1.39

0.35

2.3

3.5

—

(3013512) EKG study

214

1.25

0.34

3.8

4.0

—

(3022621) pH of Urine by Test strip

1.41

0.32

5.7

2.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1.38

0.32

2.4

3.0

6.10

7.94

umol/l

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

384

1.21

0.29

2.8

2.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

643

1.32

0.28

5.2

4.1

1.46

1.27

mmol/l

1.22

585

(3002256) Pathology report gross observation

1.34

0.27

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

1.21

0.26

1.1

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

191

1.21

0.25

4.7

5.0

3.64

1.81

ug/l

0.93

168

(3009508) Creatinine [Moles/volume] in Urine

211

1.20

0.25

3.5

2.9

7.71

7.78

mmol/l

0.02

184

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.28

0.24

2.3

2.4

2.32

2.40

g/l

0.14

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.38

0.24

1.2

1.5

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

261

1.18

0.23

1.7

1.9

103.20

98.44

pmol/l

0.11

135

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.27

0.23

1.2

1.7

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3025130) Human papilloma virus identified in Specimen

0.00

0.21

0.0

2.5

—

(3011288) Drugs identified in Urine by Screen method

0.00

0.21

0.0

1.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

0.21

0.0

4.2

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.21

0.0

2.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.21

0.0

1.2

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

0.21

0.0

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

3.5

—

15.81

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.21

0.0

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.21

0.0

1.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

0.00

0.20

0.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.20

0.0

1.6

—

(3023520) Reticulocytes [#/volume] in Blood

1.18

0.18

7.0

2.8

105.57

71.56

e9/l

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1.18

0.18

1.9

2.2

0.26

0.22

g/l

—

(3020682) Albumin/Creatinine [Ratio] in Urine

217

1.15

0.17

3.9

3.6

10.47

7.60

mg/mmol

0.13

144

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1.18

0.17

1.4

4.1

2.42

7.09

ug/l

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

683

1.27

0.15

6.4

5.2

2.98

2.77

mmol/l

1.12

625

(3021960) Folate [Moles/volume] in Serum or Plasma

159

0.85

0.15

1.6

32.51

20.75

nmol/l

0.85

136

(3044889) 12 lead EKG panel

469

0.90

0.12

4.5

3.7

—

(3041096) Erythrocytes [Presence] in Urine by Automated

175

1.11

0.09

3.2

4.0

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.07

0.08

2.3

3.3

—

(3022145) Colonoscopy Study observation

0.82

0.07

1.3

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

666

1.18

0.07

6.0

4.6

1.51

mmol/l

0.03

610

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

198

1.08

0.06

1.6

1.7

1.58

1.35

mmol/l

0.58

164

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

149

1.09

0.06

1.4

1.2

0.53

1.99

u/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

145

1.04

0.00

3.2

4.3

18.04

20.85

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.7

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.7

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.29

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

0.0

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

5.73

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.7

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

0.00

0.0

1.5

—

29.05

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.0

1.7

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

0.0

2.7

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

0.00

0.0

1.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

0.00

0.0

1.0

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.0

1.7

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

0.0

6.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.93

-0.00

1.5

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

-0.00

0.0

1.9

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

15.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.00

-0.00

0.0

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

88.75

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

180.26

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

-0.00

0.0

1.4

—

(3051611) Lipemic interference index of Serum or Plasma

0.00

-0.00

0.0

1.9

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.9

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

-0.00

0.0

1.8

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

0.92

-0.00

1.6

—

(3026389) Candida sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(4035726) Immunohistochemistry procedure

0.84

-0.00

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

0.00

-0.00

0.0

1.2

—

(21494815) CD4 cells/100 lymphocytes in Specimen

0.00

-0.00

0.0

2.1

—

33.85

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

0.00

-0.00

0.0

5.3

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

19.2

—

921.60

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.4

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

0.87

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

-0.00

0.0

1.6

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

25.4

—

1306.60

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.6

—

1.59

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

-0.00

0.0

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

(4146454) Self-monitoring of blood glucose

0.00

-0.00

0.0

2.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.3

—

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

0.00

-0.00

0.0

1.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_ERYTHINOTH and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_ERYTHINOTH.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_ERYTHINOTH – Erythema in diseases classified elsewhere

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Erythema in diseases classified elsewhere

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints